Teva Pharmaceutical Industries

Phone: +972 3-926-7267

Web: https://www.teva.co.il

Type	Public company
Traded as	TASE: TEVA NYSE: TEVA TA-35 Index Component
Industry	Pharmaceutical
Founded	1901 (1901)
Founder	Günther Friedländer Chaim Salomon Moshe Levin Yitschak Elstein
Headquarters	Tel Aviv, Israel
Key people	Richard Francis (President) and (CEO) Sol Barer (Chairman) Eli Kalif (CFO)
Revenue	US$ 15.878 Billion (2021)
Operating income	US$ 1.715 Billion (2021)
Net income	US$ 0.417 Billion (2021)
Total assets	US$ 47.666 Billion (2021)
Total equity	US$ 11.244 Billion (2021)
Number of employees	37,537 (2021)
Website	tevapharm.com teva.co.il

Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world. In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health. We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.

For detailed contact information visit location pages below.